Musa Mohammed Ali | Infectious Diseases | Best Researcher Award

Published on by Health Scientists

Dr. Musa Mohammed Ali | Infectious Diseases | Best Researcher Award 

Associate professor | Hawassa University | Ethiopia

Dr. Musa Mohammed Ali is a distinguished researcher and academic whose work exemplifies excellence in the interdisciplinary domains of microbiology, immunology, and molecular medicine. With an unwavering commitment to scientific innovation and global health advancement, he has contributed extensively to understanding pathogenic mechanisms, host–pathogen interactions, and the molecular determinants of infectious diseases. His scholarly output encompasses numerous high-quality publications in peer-reviewed international journals, reflecting both the depth of his expertise and the global recognition of his research contributions. Dr. Ali’s academic endeavors are complemented by successful collaborations with national and international research institutions, where he has actively participated in multidisciplinary projects addressing critical health challenges affecting communities worldwide. His research has not only enriched the scientific understanding of microbial pathogenesis but also informed the development of diagnostic tools, preventive strategies, and therapeutic interventions aimed at reducing disease burden in vulnerable populations. Through his commitment to mentoring young scientists and fostering collaborative research ecosystems, Dr. Ali has helped strengthen institutional research capacity and knowledge exchange across borders. His academic vision aligns with advancing translational research that bridges laboratory discoveries with public health outcomes, promoting innovation and sustainability in healthcare systems. Widely respected for his analytical rigor, leadership in scientific inquiry, and dedication to ethical research, Dr. Musa Mohammed Ali continues to make impactful contributions that resonate across academia, healthcare, and society, reinforcing the vital connection between scientific excellence and human wellbeing. He has 1615 citations from 57 documents with an h-index of 13.

Profiles: Google Scholar | Scopus | ORCID

Publications

1. Trends of neonatal sepsis and its etiology at Hawassa, Ethiopia: A five-year retrospective cross-sectional study. (2025). BMC Pediatrics.

2. Malaria and soil transmitted helminth infection and associated factors among pregnant women attending public health facilities in Dilla town, South Ethiopia: Cross-sectional study design. (2025). BMC Infectious Diseases.

3. Prevalence of drug-resistant Mycobacterium tuberculosis and its associated factors among tuberculosis patients attending Dilla University Referral Hospital, Ethiopia. (2025). BMC Infectious Diseases.

4. Nasal colonizing vancomycin-resistant and intermediate Staphylococcus aureus among admitted patients: A hospital-based cross-sectional study. (2025). Health Science Reports.

5. Prevalence of hepatitis B virus infection among pregnant women and cord blood hepatitis B surface antigen positive newborns in sub-Saharan Africa and South Asia. (2025). Journal of Clinical Virology.

Ayesha Zainab Beg | Infectious Diseases | Best Researcher Award

Published on by Health Scientists

Dr. Ayesha Zainab Beg | Infectious Diseases | Best Researcher Award 

Post Doctoral Scientist | Columbia University | United States

Dr. Ayesha Zainab Beg is a Postdoctoral Research Scientist in the Department of Pediatrics at Columbia University Irving Medical Center (CUIMC), New York, where she investigates airway host–pathogen interactions with a focus on microbial pathogenesis and immunometabolism. She earned her Ph.D. in Biotechnology from Aligarh Muslim University, India, where her doctoral research elucidated the role of Pseudomonas aeruginosa biofilm components, particularly the functional amyloid Fap, in chronic airway infections and pathoadaptation, leading to seven peer-reviewed publications. She also holds an M.Sc. in Biotechnology and a B.Sc. (Hons.) in Biochemistry from the same institution. Dr. Beg’s current work explores how the cystic fibrosis airway environment drives adaptive genetic alterations in clinical isolates of P. aeruginosa and how airway immunometabolites regulate bacterial proteomes via post-translational modifications. Her research highlights include studies on Fap phosphorylation, multi-epitope vaccine design against functional amyloids, and the impact of bacterial metabolites on pulmonary infections, with recent publications in Journal of Biomolecular Structure and Dynamics, Nature Communications, and Microbiology Spectrum. She has presented her work at major conferences including ATS, Cold Spring Harbor Laboratory, and ECCMID, and has been recognized with multiple fellowships and awards, including the Young Achiever Award  and Research Excellence Award. Her expertise spans molecular microbiology, proteomics, metabolomics, immunoinformatics, and murine models of infection, making her a leading early-career researcher at the interface of host–pathogen interactions and metabolic regulation. She has 153 citations from 10 documents with an h-index of 4.

Profiles: Google Scholar | Scopus | ORCID

Publications

1. Alam, P., Beg, A. Z., Siddiqi, M. K., Chaturvedi, S. K., Rajpoot, R. K., Ajmal, M. R., … (2017). Ascorbic acid inhibits human insulin aggregation and protects against amyloid-induced cytotoxicity. Archives of Biochemistry and Biophysics.

2. Beg, A. Z., Farhat, N., & Khan, A. U. (2021). Designing multi-epitope vaccine candidates against functional amyloids in Pseudomonas aeruginosa through immunoinformatic and structural bioinformatics approach. Infection, Genetics and Evolution.

3. Beg, A. Z., Rashid, F., Talat, A., Haseen, M. A., Raza, N., Akhtar, K., Dueholm, M. K. D., … (2023). Functional amyloids in Pseudomonas aeruginosa are essential for the proteome modulation that leads to pathoadaptation in pulmonary niches. Microbiology Spectrum.

4. Beg, A. Z., & Khan, A. U. (2018). Genome analyses of blaNDM-4 carrying ST 315 Escherichia coli isolate from sewage water of one of the Indian hospitals. Gut Pathogens.

5. Beg, A. Z., & Khan, A. U. (2019). Exploring bacterial resistome and resistance dissemination: An approach of whole genome sequencing. Future Medicinal Chemistry.

Suresh Arumugam | Infectious Diseases | Best Researcher Award

Published on by Health Scientists

Dr. Suresh Arumugam | Infectious Diseases | Best Researcher Award

Scientist | Meenakshi Medical College Hospital and Research Institute | India

Dr. A. Suresh is a distinguished microbiologist and currently serves as Scientist cum Research Coordinator at the Central Research Laboratory, Meenakshi Medical College Hospital & Research Institute, Kanchipuram, with over 17 years of academic experience and 9 years of corporate expertise. He holds a Ph.D. in Microbiology from the University of Madras, an M.Phil. in Biotechnology from Bharathidasan University, and an M.Sc. in Applied Microbiology from Sri Sankara Arts and Science College under the University of Madras. His primary research areas span infectious diseases, antimicrobial resistance, natural product-based drug discovery, and genome annotation, where he has significantly contributed through genomic data submissions, innovative patents, and translational studies. Dr. Suresh has authored and co-authored more than 70 peer-reviewed publications in high-impact journals including the Journal of Medical Virology, Molecular Biology Reports, Drug Delivery Science and Technology, and Luminescence, highlighting his multidisciplinary expertise across microbiology, biotechnology, and clinical research. His scientific contributions have been recognized through several awards, including distinctions for innovation in natural product drug discovery and his leadership in antimicrobial stewardship. Beyond his research, Dr. Suresh has played a pivotal role as Ph.D. supervisor, doctoral committee member, and academic coordinator, mentoring young researchers and advancing scientific education. He also contributes to the wider scientific community as an editorial board member and peer reviewer for reputed international journals, ensuring the dissemination of high-quality research. Dr. Suresh’s career embodies a balance of scientific discovery, innovation, and academic mentorship, positioning him as a thought leader in microbiology and drug discovery research. He has 360 citations from 68 documents with an h-index of 8.

Profiles: Google Scholar | Scopus | ORCID

Publications

1. Mohan, K., Srinivasan, S., Selvaraj, S., Suresh, A., & Krishnamoorthy, A. (2025). A study on dengue infection, seroprevalence and its seasonal distribution among patients attending a tertiary care hospital, Kanchipuram, India. Journal of Applied Pharmaceutical Science.

2. Kaliaperumal, K., Aboobacker, J., Dhanapal, V., Gayathri, A., Subramanian, K., Suresh, A., Elumalai, S., Sampath, S., Devanesan, S., AlSalhi, M. S., et al. (2025). Bioremediation of malachite green dye using Sargassum wightii seaweed and its biological and physicochemical characterization. Open Chemistry.

3. Kamalanathan, J., Suresh, M. S., Rajendran, V., AlSalhi, M., Devanesan, S., Suresh, A., Joseph, J., & Sampath, S. (2025). Nuclear staining and fluorogenic probe–based evaluation of ROS-cytotoxic potential using AgNPs synthesized from Cajanus trinervius against A431 cell line. Luminescence.

4. Suresh, A., Muninathan, N., Sampath, S., Devanesan, S., AlSalhi, M. S., & Manoj, D. (2025). Role of traditional and new biomarkers in the assessment of chronic kidney diseases: A comprehensive analysis of the biochemical, molecular and clinical dimensions. Molecular Biology Reports.

5. Rajeswari, M. V., Suresh, A., Thirumalaikumar, E., Subramanian, K., Kaliaperumal, K., Sampath, S., Devanesan, S., & AlSalhi, M. S. (2025). Efficacy of chitosan conjugated bivalent vaccine on immune response and disease resistance against Aeromonas hydrophila and Aeromonas caviae in goldfish (Carassius auratus). Journal of Drug Delivery Science and Technology.

6. Christina, B., Poongkuzhali, S., Muninathan, N., Bhaskaran, K., & Suresh, A. (2025). The mechanisms and therapeutic potential of the microbiome-immune interface in cancer. Discover Biotechnology.